Clik here to view.
NEC的人工智能(AI)帮助医生确定结直肠病灶有无癌变
东京 (美国商业资讯)–NEC Corporation (NEC; TOKYO: 6701)今天宣布一项人工智能技术取得进展，该技术可帮助医生确定结直肠病灶是否属于癌变。NEC开发了一项名为“Cx20”的新技术，同时寻求早期检出结直肠病灶的辅助手段。Cx20已达到欧洲安全、健康和环保标准CE标志的要求，并将整合到医疗器械AI诊断支持软件“WISE VISION®...
View ArticleClik here to view.
Bio-Thera Solutions Announces the First Patient Dosed in Phase III Clinical...
GUANGZHOU, China Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage pharmaceutical company, today announced that the first patient has been dosed in a Phase III clinical study for BAT2206, a...
View ArticleClik here to view.
CANbridge Pharmaceuticals CAN106 Investigational New Drug Application...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development and...
View ArticleClik here to view.
Patented Thread Lifting ‘TIMEMACHINE LIFT ANCHORING DUAL COG’ Proven to...
SEONGNAM, South Korea SENSCO, a Korean professional medical device Thread Lift manufacturing company, said that its thread lifting, TIMEMACHINE LIFT ANCHORING DUAL COG (https://timemachinelift.com/)...
View ArticleClik here to view.
Regencell Bioscience Holdings Limited Announces Pricing of Approximately...
HONG KONG Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of...
View ArticleClik here to view.
GC LabCell and GC Cell to Merge, Creating a Premier Cell Therapy Company
YONGIN, South Korea GC LabCell (KOSDAQ: 144510) and GC Cell (KOSDAQ: 031390) today announced that they have entered into a definitive merger agreement to combine in an all-stock transaction. The...
View ArticleClik here to view.
Kyowa Kirin Announces EU Approval for the Self-administration of CRYSVITA® ▼...
TOKYO Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin) today announced that CRYSVITA® (burosumab) has been approved for the option of self-administration in the European Union (EU) for the treatment of...
View ArticleClik here to view.
Brain Mapping Pioneer Omniscient Neurotechnology Raises AUD 40 Million in...
SYDNEY Omniscient Neurotechnology (“o8t™”), a pioneering brain mapping technology company, today announced the completion of an AUD 40 million Series B financing round. The funding was led by family...
View ArticleClik here to view.
Regencell Bioscience Holdings Limited、2190万ドル規模の新規株式公開を実施
香港 （ビジネスワイヤ） — 神経認知障害および変性症治療（特に注意欠陥・多動性障害（ADHD）と自閉症スペクトラム障害（ASD））のための中国漢方薬（TCM）の研究・開発・商業化に取り組む早期段階のバイオサイエンス企業Regencell Bioscience Holdings...
View ArticleClik here to view.
Moderna Partners with Takeda and the Government of Japan to Supply Additional...
CAMBRIDGE, Mass. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Ministry of Health, Labour and Welfare of...
View ArticleClik here to view.
Guided Therapeutics Receives News from Chinese State Food and Drug...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva™ Advanced Cervical Scan, based on its patented biophotonic technology, announced today its Chinese...
View ArticleClik here to view.
Sesen Bio and Qilu Pharmaceutical Announce Enrollment of First Patient in...
CAMBRIDGE, Mass. Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and its partner in Greater China,...
View ArticleClik here to view.
Canon Medical Announces Strategic Changes to Reinforce Global HIT Division
OTAWARA, Japan Canon Medical Systems Corporation has today announced a major operational plan to strengthen its healthcare information technology (HIT) division. The HIT division will broaden its...
View ArticleClik here to view.
Regencell Bioscience Holdings Limited宣布约2,190万美元的首次公开发行定价
香港 (美国商业资讯)–Regencell Bioscience Holdings...
View ArticleClik here to view.
Regencell Bioscience Holdings Limited Announces Closing of Initial Public...
HONG KONG Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of...
View ArticleClik here to view.
Olympus to Support Endoscopic AI Diagnosis Education for Doctors in Thailand
TOKYO Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) took part in a ground-breaking project as a business promoter, in cooperation with the Ministry of...
View ArticleClik here to view.
Exscientia and GT Apeiron Therapeutics Enter Oncology Joint Venture
OXFORD & SHANGHAI Exscientia, an AI-driven pharmatech company with a mission to revolutionise how drugs are discovered, and GT Apeiron Therapeutics （Apeiron）, a Shanghai based company focused on...
View ArticleClik here to view.
冠科生物投资于商业领导力
圣迭戈 (美国商业资讯)–JSR生命科学公司旗下冠科生物今天宣布，任命Alex Slater为北美暨欧洲业务开发副总裁。在此职位上，Slater先生将负责公司现有服务阵容的持续增长，并为拓展新服务奠定基础。...
View ArticleClik here to view.
Omniscient Neurotechnology Launches Quicktome™ Brain Mapping Platform for...
SYDNEY, Australia Omniscient Neurotechnology (“o8t™”), a pioneering brain mapping software company, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
View ArticleClik here to view.
クラウン・バイオサイエンスが商業幹部職の新設に投資
サンディエゴ （ビジネスワイヤ） — JSRライフサイエンス傘下のクラウン・バイオサイエンスは本日、アレックス・スレーターを事業開発担当バイスプレジデント（北米・欧州）に任命したことを発表します。スレーターはこの役職で、当社の既存サービスポートフォリオを継続的に成長させ、新サービスを拡大するための基盤を築く業務を担当します。...
View Article